@curator

2 years ago

Article

Anthem, Biogen, Eli Lilly and Pfizer develop digital endpoint toolkit to guide drug reimbursement decisions

Rating: 0.0

Likes: 1

Library: 1

Anthem, Biogen, Eli Lilly and Pfizer develop digital endpoint toolkit to guide drug reimbursement decisions

The pharmaceutical industry is making progress to incorporate digital endpoints into clinical trials as the industry shifts to decentralized clinical trials and as digital evidence plays a big | To prepare for the first drug labels and approvals based on data from digital endpoints, the nonprofit Digital Medicine Society partnered with Anthem and major pharmaceutical companies to develop a toolkit to support reimbursement for new drugs developed using digital endpoints.

Rate This Post

Rate The Educational Value

Rate The Ease of Understanding and Presentation

Interesting or Boring? Rate the Entertainment Value

Anthem, Biogen, Eli Lilly and Pfizer develop digital endpoint toolkit to guide drug reimbursement decisions

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge
for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge
for Humanity's Progress

Anthem, Biogen, Eli Lilly and Pfizer develop digital endpoint toolkit to guide drug reimbursement decisions

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress